Lincoln Pharma … the next mid-cap pharma in the making …?

Sorry for the digression.

Hi @ayushmit,

From a corporate governance standpoint, I think you would agree that these transactions (images below) create doubt in the mind of an investor as to its legitimacy.

My question is more on:

1. How much do you weigh them in your investment process (Do you discard a company right away) or
2. Do you still continue the research and even invest in such situations ?

Just trying to understand, is this an absolute deal breaker according to you ? Also, how do you see companies purchasing inputs or selling most of their products from/to related parties ? Again a deal breaker or you continue further.

If these are not your deal breaker, can you please share your major red flags beyond which you move on to the next company ?

Thanks in advance!